To support it is a recent research of the Instituto de Biologi’y Gene’tica Molecular (IBGM) published in the magazine British Journal of Pharmacology.
According to the data, some disease would progress much more slowly thanks to the active ingredient content in the oleanolic acid.
In the course of research, scientists have studied some models of animals with multiple sclerosis and experimental autoimmune encephalomyelitis (EAE).
Maria Luisa Nieto, one of the coordinators of the research, explained that the disease develops much more slowly when it is administered the active ingredient. But c’è più, explains Nieto, “in some cases we were able to significantly reduce and even eliminate all the inflammatory processes associated with the disease.”
in Short, the active ingredient has been shown to be able to alleviate some of the clinical features such as weight and muscle control. Alterations in the immuno-inflammatory attenuate as impermeabilità vascular infiltration of leukocytes, the presence of cytokines.
Now is the intention of the researchers to proceed with research for other diseases.
8 may 2012